Results 151 to 160 of about 58,665 (272)
Could Dopamine Agonists Aid in Drug Development for Anorexia Nervosa? [PDF]
, 2014 Guido Frank
openalex +1 more source
British Journal of Pharmacology, EarlyView.Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller +3 more
wiley +1 more source
Prolactin secreting pituitary neuroendocrine tumors treated by dopamine agonists: predictors of response. [PDF]
Front Endocrinol (Lausanne)Mele C +12 more
europepmc +1 more source
Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis. [PDF]
Chin Neurosurg J, 2022 Cai X +5 more
europepmc +1 more source
Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment [PDF]
, 1997 Annamaria Colao
openalex +1 more source
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
British Journal of Pharmacology, EarlyView.Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
PLoS Biology, 2005 Brain dopamine is critically involved in movement control, and its deficiency is the primary cause of motor symptoms in Parkinson disease. Here we report development of an animal model of acute severe dopamine deficiency by using mice lacking the ...
doaj +1 more source
Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists. [PDF]
Front Endocrinol (Lausanne), 2021 Tang H +5 more
europepmc +1 more source